Search by Drug Name or NDC
NDC 60977-0141-01 Protopam Chloride 1 g/20mL Details
Protopam Chloride 1 g/20mL
Protopam Chloride is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is PRALIDOXIME CHLORIDE.
Product Information
| NDC | 60977-0141 |
|---|---|
| Product ID | 60977-141_a677d997-e5d4-418c-8a32-32692b30988d |
| Associated GPIs | 93000070102105 |
| GCN Sequence Number | 002557 |
| GCN Sequence Number Description | pralidoxime chloride VIAL 1 G INJECTION |
| HIC3 | C8D |
| HIC3 Description | CHOLINESTERASE REACTIVATING,ORGANOPHOS. ANTIDOTES |
| GCN | 07191 |
| HICL Sequence Number | 001111 |
| HICL Sequence Number Description | PRALIDOXIME CHLORIDE |
| Brand/Generic | Brand |
| Proprietary Name | Protopam Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | pralidoxime chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/20mL |
| Substance Name | PRALIDOXIME CHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Cholinesterase Reactivator [EPC], Cholinesterase Reactivators [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA014134 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60977-0141-01 (60977014101)
| NDC Package Code | 60977-141-01 |
|---|---|
| Billing NDC | 60977014101 |
| Package | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) / 20 mL in 1 VIAL, SINGLE-DOSE (60977-141-27) |
| Marketing Start Date | 1965-03-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |